In this Section |
157867 Access denied: Political, regulatory, and institutional barriers to emergency contraception access in PalestineWednesday, November 7, 2007: 3:00 PM
Introduction: In the Arab world, dedicated emergency contraceptive pills (ECPs) have been registered in Algeria, Egypt, Lebanon, Libya, Tunisia, Yemen, as well as Israel, and thus, theoretically, Palestine. The aim of our study is to better understand the political, institutional, and regulatory factors influencing the status and availability of emergency contraception (EC) in Palestine (defined as East Jerusalem, the West Bank, and the Gaza Strip). Methods: Our situation analysis is informed by a review of regulatory and policy documents, in-depth interviews with government, United Nations Relief Works Agency (UNRWA), and NGO representatives, and discussions with clinicians and pharmacists in East Jerusalem and the West Bank. Results: ECPs are not incorporated into the UNRWA health system and thus not available to refugees. While Postinor-2 is available in Israel and parts of East Jerusalem, dedicated ECPs are not available in the West Bank or Gaza. Thus Palestinian women without a Jerusalem identity card or Israeli work permit are unable to access ECPs. Although oral contraceptive pills are widely available in Palestine, few clinicians or pharmacists are aware of their potential for postcoital use. Conclusion: The worsening political situation, frequent curfews, restrictions on movement, and sexual violence contribute to high rates of unintended pregnancy among Palestinian women. Refugee and unmarried women are particularly vulnerable and EC has the potential to make a significant contribution to reproductive health in Palestine. Our study points to several avenues for expanding access to EC, including reform of UNWRA policies and educational campaigns targeting clinicians and pharmacists.
Learning Objectives: Keywords: International Reproductive Health, Vulnerable Populations
Presenting author's disclosure statement:
Any relevant financial relationships? No I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
See more of: International Issues in Emergency Contraception
See more of: Population, Family Planning, and Reproductive Health |